|
MPHOSPH9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-16 |
| Normal-vs-Stage2 |
8.12390044124811E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.121400E-01 |
| Stage1-vs-Stage3 |
1.131420E-01 |
| Stage1-vs-Stage4 |
1.921580E-02 |
| Stage2-vs-Stage3 |
4.018300E-02 |
| Stage2-vs-Stage4 |
1.158200E-02 |
| Stage3-vs-Stage4 |
4.518400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.27420029661619E-10 |
| Normal-vs-Asian |
1.62814206561279E-12 |
| Caucasian-vs-AfricanAmerican |
3.635000E-01 |
| Caucasian-vs-Asian |
5.173600E-01 |
| AfricanAmerican-vs-Asian |
2.035000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
4.318600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.18793863634892E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
2.46879999999949E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.799000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.486000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.074400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.030400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.417800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.690000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.123700E-02 |
| Classical-VS-Follicular |
1.086180E-01 |
| Classical-VS-Other |
1.782760E-01 |
| Classical-VS-Normal |
1.63069557856943E-12 |
| Tall-VS-Follicular |
7.623400E-03 |
| Tall-VS-Other |
6.637600E-01 |
| Tall-VS-Normal |
2.1094237467878E-15 |
| Follicular-VS-Other |
7.484300E-03 |
| Follicular-VS-Normal |
1.66299999992958E-07 |
| Other-VS-Normal |
6.23450002734671E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.680220E-03 |
|
|
